<strong>Shoppers</strong> <strong>Drug</strong> <strong>Mart</strong> CorporationCondensed Consolidated <strong>Statements</strong> of Changes in Shareholders' Equity(unaudited)(in thousands of Canadian dollars)NoteShareCapitalTreasurySharesContributedSurplusAccumulatedOtherComprehensiveLossRetainedEarningsBalance as at December 31, 2011 $ 1,486,455 $ (4,735) $ 10,246 $ (30,214) $ 2,806,078 $ 4,267,830Total comprehensive income — — — 88 433,216 433,304Dividends 9 — — — — (165,613) (165,613)Share repurchases 9, 10 (43,745) (3,076) — — (215,655) (262,476)Treasury shares cancelled 9 (810) 4,735 — — (3,925) —Share-based payments 11 — — 615 — — 615Share options exercised 11 1,297 — (179) — — 1,118Repayment of share-purchaseloans 10 — — — — 10Balance as at October 6, <strong>2012</strong> $ 1,443,207 $ (3,076) $ 10,682 $ (30,126) $ 2,854,101 $ 4,274,788TotalBalance as at January 1, 2011 $ 1,520,558 $ — $ 11,702 $ (8,643) $ 2,579,018 $ 4,102,635Total comprehensive income — — — 305 437,915 438,220Dividends 9 — — — — (162,552) (162,552)Share repurchases 9, 10 (16,623) (12,611) (75,547) (104,781)Share-based payments 11 — — (1,394) — — (1,394)Share options exercised 11 1,210 — (246) — — 964Repayment of share-purchaseloans 7 — — — — 7Balance as at October 8, 2011 $ 1,505,152 $ (12,611) $ 10,062 $ (8,338) $ 2,778,834 $ 4,273,099The accompanying notes are an integral part of these condensed consolidated financial statements.29
<strong>Shoppers</strong> <strong>Drug</strong> <strong>Mart</strong> CorporationCondensed Consolidated <strong>Statements</strong> of Cash Flows(unaudited)(in thousands of Canadian dollars)Cash flows from operating activities30NoteOctober 6,<strong>2012</strong>16 weeks ended 40 weeks endedOctober 8,2011October 6,<strong>2012</strong>October 8,2011Net earnings $ 168,273 $ 172,449 $ 433,216 $ 437,915Adjustments for:Depreciation and amortization 98,068 91,354 242,759 225,692Finance expenses 17,638 19,732 44,285 49,171(Gain) loss on sale or disposal of property and equipment (11,382) (2,467) (9,057) 1,164Share-based payment transactions 79 128 615 (1,394)Recognition and reversal of provisions, net 2,566 2,900 14,230 9,480Other long-term liabilities 2,231 1,483 1,932 6,780Income tax expense 59,123 64,593 153,425 167,830336,596 350,172 881,405 896,638Net change in non-cash working capital balances 12 (30,428) (59,453) (104,699) (65,611)Provisions used (6,486) (5,083) (10,986) (8,166)Interest paid (13,585) (17,589) (46,819) (48,950)Income tax paid (52,256) (59,683) (169,777) (169,432)Net cash from operating activities 233,841 208,364 549,124 604,479Cash flows from investing activitiesProceeds from disposition of property and equipment 43,213 34,229 50,709 39,518Business acquisitions 4 (83,209) (405) (96,157) (6,657)Deposits 5,476 (410) (28,922) (875)Acquisition and development of property and equipment (64,613) (103,524) (174,368) (241,982)Acquisition and development of intangible assets (14,180) (20,329) (39,546) (36,643)Other assets 424 5,598 1,212 805Net cash used in investing activities (112,889) (84,841) (287,072) (245,834)Cash flows from financing activitiesRepurchase of own shares 9 (94,416) (92,170) (264,135) (92,170)Proceeds from exercise of share options 406 358 1,118 964Repayment of share-purchase loans — — 10 7Bank indebtedness, net (16,189) (5,483) 82,708 31,967Issuance (repayment) of commercial paper, net 8 39,000 — 263,000 (128,000)Repayment of long-term debt 8 — — (250,000) —Revolving term debt, net — — (152) —Repayment of financing lease obligations (910) (688) (2,206) (1,555)Associate interest 11,410 9,641 6,162 (92)Dividends paid 9 (55,154) (54,369) (164,053) (157,664)Net cash used in financing activities (115,853) (142,711) (327,548) (346,543)Net increase (decrease) in cash 5,099 (19,188) (65,496) 12,102Cash, beginning of period 47,971 95,644 118,566 64,354Cash, end of period $ 53,070 $ 76,456 $ 53,070 $ 76,456The accompanying notes are an integral part of these condensed consolidated financial statements.